# Class II Invariant Chain HCV Vaccine Study

> **NCT03688061** · PHASE1 · COMPLETED · sponsor: **University of Oxford** · enrollment: 25 (actual)

## Conditions studied

- Hepatitis C

## Interventions

- **BIOLOGICAL:** ChAd3-hliNSmut
- **BIOLOGICAL:** MVA-hliNSmut

## Key facts

- **NCT ID:** NCT03688061
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-12-04
- **Primary completion:** 2019-08-04
- **Final completion:** 2022-08-04
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2023-05-10

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03688061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03688061, "Class II Invariant Chain HCV Vaccine Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03688061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*